Discover 605 paid clinical trials in Edmond, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 605
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
for
Chronic Migraine
Location: 38 recruiting locations
Sponsor: Merz Therapeutics GmbH
Sex: All
Age: 18+
Code: NCT07018713
Phase3, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: 123 recruiting locations
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase3, Recruiting
Active & Responsive
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis
Get alerts for new trials in your area by subscribing now
Active & Responsive
Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain
for
Degenerative Disc Disease
Location: 39 recruiting locations
Sponsor: Mesoblast, Ltd.
Sex: All
Age: 18+
Code: NCT06325566
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
for
SARS-CoV-2
Location: 128 recruiting locations
Sponsor: ModernaTX, Inc.
Sex: All
Age: 50 - 64
Code: NCT07266558
Recruiting
Active & Responsive
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus
Location: 108 recruiting locations
Sponsor: AbbVie
Sex: All
Age: 18 - 63
Code: NCT05843643
Phase3, Recruiting
Active & Responsive
Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)
for
Plantar Fibromatosis, Ledderhose Disease
Location: 53 recruiting locations
Sponsor: Endo Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06151197
Phase3, Recruiting
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome